• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.36 número6

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.36 número6"

Copied!
6
0
0

Texto

(1)

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

w w w . r b h h . o r g

Original

article

Palliative

care

in

pediatric

hematological

oncology

patients:

experience

of

a

tertiary

hospital

Maria

Thereza

Macedo

Valadares,

Joaquim

Antônio

César

Mota,

Benigna

Maria

de

Oliveira

UniversidadeFederaldeMinasGerais(UFMG),BeloHorizonte,MG,Brazil

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received21January2013

Accepted25June2014

Availableonline18September2014

Keywords:

Palliativecare

Neoplasms Death

a

b

s

t

r

a

c

t

Objective:Toevaluatetheapproachtopalliativecareforhematologicaloncologypatientsin

thepediatricwardofatertiaryhospital.

Methods:Thiswasaretrospective,descriptivestudyof29hematologicaloncologypatients

whodiedbetween2009and2011.Dataregardingtheapproachandprevalenceofpain,

preva-lenceofothersymptoms,multidisciplinaryteamparticipation,communicationbetween

staffandfamilyandlimitedinvasivetherapywerecollectedfromthemedicalrecords.

Results:Twenty-seven(93.1%)patientsdisplayeddiseaseprogressionunresponsiveto

cura-tivetreatment.Themedianageatdeathwastenyearsold.Painwasthemostprevalent

symptomwithallpatientswhoreportedpainreceivinganalgesicmedications.Themajority

tookweak(55.2%)and/orstrong(65.5%)opioids.Thepatientswerefollowedbypediatricians

andapediatrichematologist/oncologist.Participationofotherprofessionalswasalso

doc-umented:86.2%werefollowedbysocialservicesand69%bypsychologists,amongothers.

Therewereexplicitdescriptionsoflimitationofinvasivetherapyinthemedicalrecordsof

26patientswhodiedwithdiseaseprogression.Allthesedecisionsweresharedwiththe

families.

Conclusion: Althoughthehospitalwherethisstudywasconducteddoesnothavea

special-izedteaminpediatricpalliativecare,itmeetsalltherequirementsfordevelopingaspecific

program.Theimportanceofapproachingpainandotherprevalentsymptomsinchildren

withcancerinvolvingacomprehensivemultidisciplinaryteamisevident.Discussionswere

hadwithmostofthefamiliesonlimitinginvasivetherapy,butnorecordofawell-defined

andcoordinatedtreatmentplanforpalliativecarewasfound.

©2014Associac¸ãoBrasileiradeHematologia,HemoterapiaeTerapiaCelular.Published

byElsevierEditoraLtda.Allrightsreserved.

Correspondingauthorat:UniversidadeFederaldeMinasGerais(UFMG),Av.AlfredoBalena,190,sala267,30130-100BeloHorizonte,MG,

Brazil.

E-mailaddress:benigna@uol.com.br(B.M.deOliveira).

http://dx.doi.org/10.1016/j.bjhh.2014.09.003

1516-8484/©2014Associac¸ãoBrasileiradeHematologia,HemoterapiaeTerapiaCelular.PublishedbyElsevierEditoraLtda.Allrights

(2)

Introduction

Palliativecareinpediatricsis,accordingtotheWorldHealth

Organization,activeandtotalcaredeliveredtoachildin

rela-tiontohisorherbody,mindandsoul,withsupportprovidedto

thewholefamily.Thefocusofthisapproachisearly

identifi-cationandtreatmentofpainandothersymptomswithaview

toprovidingpatientsandtheirfamilieswiththebestquality

oflifepossible.1

There are currentlymany childreninneed ofpalliative

care2includingpatientswithneoplasms.Everyyear,200,000

childrenandadolescentsarediagnosedwithcanceraround

theworld.InBrazil,themortalityrateofchildrenand

adoles-centsagedbetweenoneand19duetocancerwas8%in2005

makingthisthesecondleadingcauseofdeathandthefirst

leadingcauseofdeathbydiseaseinthispopulation.Global

initiatives toprovide careforthesechildrenare,therefore,

necessaryandurgent.3,4

Thisstudyaimedtoevaluatetheapproachofpalliativecare

inhematologicaloncologypatientswhoprogressedtodeath

inthepediatricwardofatertiaryhospital.

It is important to state that palliative care should be

introduced at the time of diagnosis. However, as

cura-tivemeasuresdecrease,palliativecarebecomesanabsolute

necessity5and forthisreason,the studysamplewas

com-posedofpatientswhodied.

Methods

This was a retrospective, descriptive Study that included

allunder18-year-oldpatientsdiagnosedwithhematological

oncologydiseaseswhodiedinthepediatricwardofthe

Hos-pitaldas Clínicas atUniversidade Federalde Minas Gerais

(HC-UFMG)between2009and2011.

Patients withother diseases who also neededpalliative

careandprogressedtodeathwereexcludedaswerepatients

with hematological oncology diseases who died in their

homes,emergencyservices,intensivecareunitsorinother

hospitals.

Data were collected through analysis of the medical

records.Thesedatarefertothehospitalizationduringwhich

thepatientsdied.

The assessed data relate to the main items that

con-stitutegood assistanceinpalliativecare:approachtopain,

prevalenceofpainandothersymptoms,involvementofa

mul-tidisciplinary team, communication between medical staff

andfamily/patientonthecaseanddiseaseprogression,the

family’sdesiretogohome,patientfollow-upbythehomecare

serviceandlimitationofinvasivetherapy.

Thestudywasapprovedbythehospital’sResearchEthics

Committee,whichwaivedinformedconsent.

Results

Between2009and2011,44deathswererecordedinthe

pedi-atricwardoftheHC-UFMG.Ofthose,29(66%)werepatients

withhematologicaloncologydiseases,whowereincludedin

thestudy.

Ofthe29patientsthatdied,themedianagesatthetime

ofdiagnosisanddeathweresixandtenyears,respectively.

Forty-fivepercenthadhematologicaldiseases(aplastic

ane-miaor leukemia)and 55% hadsolid tumors.Twenty-seven

(93.1%)displayeddiseaseprogressionunresponsivetocurative

treatment.Ofthese,threepatientsreceivedchemotherapyas

apalliativemeasureandonlyonereceivedchemotherapywith

curativeprospects,evenwithdiseaseprogressionandlimited

invasivetherapy.

Tenpatients(34.4%)displayedneurologicalsequelae,with

varying degrees of cognitive deficit. Six patients were

tra-cheostomized(allwithneurologicalsequelae:#4,#9,#12,#16,

#18,#24),thirteenhadbeenusinganenteraltubeandonehad

agastrostomy.

Themediandurationofhospitalizationwas40days.Eight

patients(27.5%)wereadmittedintotheintensivecareunitat

leastonceduringhospitalization.

Data regarding the characterization of the sample are

showninTables1and2.

Themediannumber ofsymptomsdisplayedper patient

wasfour.Themainsymptomsandtheirprevalencesarelisted

inTable3.Painwasthemostprevalentsymptom,reportedby

almost80%ofthepatients.

All patients reporting pain took analgesic medications:

48.3% tookcommonanalgesicsbut themajoritytookweak

and/or strong opioids (55.2 and 65.5%, respectively). Three

patientswerefollowedupinthepainclinic.Therewereno

recordsofscalesornon-pharmacologicalmeasurestocontrol

painbeingused.

All patientswere followed up bygeneral pediatric

resi-dentsfullysupervisedbypreceptorsonthehospital’sclinical

staff. All patients were assisted bypediatric hematologists

oroncologistsasrequiredbytheirunderlyingdiseases.The

Table1–Characteristicsofthe29hematological oncologypatientswhoprogressedtodeath.

Characteristics

Gender(male:female) 18:11

Ageattimeofdiagnosis(years)

Median 6

Variation 1–16

Interquartilerange(25–75%) 2.5–9.5

Ageattimeofdeath(years)

Median 10

Variation 1–17

Interquartilerange(25–75%) 4.5–13

SymptomsreportedthroughoutHospitalization(n)

Median 4

Variation 0–8

Interquartilerange(25–75%) 3–6

Intervalbetweendiagnosisofanddeath(years)

Median 1.1

Variation 0.1–10

Interquartilerange(25–75%) 0.7–3.8

Durationofhospitalizationwhenpatientdied(days)

Median 40

Variation 3–246

(3)

Table2–Diagnosis,neurologicalsequelaeanduseofchemotherapyatthetimeofdeath.

Patient# Diagnosis Useofchemotherapyatthetimeofdeath Neurologicalsequelae

3,7,21 Aplasticanemia Doesnotapply No

12,16,18 Anaplasticastrocytoma No Yes

9 Adrenocorticalcarcinoma No Yes

11 Adrenalglandcarcinoma Noexplicitreportfound Yes

4 Chordoma No Yes

10 Anaplasticependymoma Noexplicitreportfound Yes

5 Glioma No Yes

20 Glioblastoma No No

8 Hepatoblastoma No No

14,15,17,22 ALL No No

25 ALL Curative No

13,28 ALL Palliative No

2,19 Acutemyeloidleukemia Curative No

23 Myeloidleukemia Palliative No

24 Medulloblastoma No Yes

26 Neuroblastoma No No

27 Neurofibroma No No

29 Osteosarcoma Noexplicitreportfound No

6 Brainstemtumor Noexplicitreportfound Yes

ALL:acutelymphocyticleukemia.

Table3–Prevalenceofthesymptomsdisplayedduring thehospitalizationinwhichthepatientdied.

Symptom n %

Pain 23 79.3

Dyspnea 20 69.0

Nausea/vomiting 18 62.1

Constipation 15 51.7

Depressedmood 13 44.8

Hyporexia 10 34.5

Anxiety 7 24.1

Sleepchanges 4 13.8

Weakness 3 10.3

Irritability 3 10.3

involvementofothermedical staffisshown inTable4. Of

the patientsfollowed up bythe psychiatry department,all

wereprescribedpsychiatricmedications(antidepressantsand

anxiolytics)and onlyone wasnotsimultaneously followed

upbythepsychologydepartment.Thepsychologyapproach,

Table4–Numberofpatientswhoreceivedcarefromthe differentprofessionalsinthemultidisciplinaryteam duringthehospitalizationinwhichthepatientdied.

Professional n %

Pediatricresident/preceptor 29 100.0

Staffnurses 29 100.0

Socialworker 25 86.2

Pediatriconcologist 16 55.0

Pediatrichematologist 13 45.0

Psychologist 20 69.0

Nutritionist 16 55.0

Physicaltherapist 11 37.9

Occupationaltherapist 8 27.6

Psychiatrist 5 17.2

Painclinic 3 10.3

Religioussupport 1 3.5

in its turn, was considered for both family members and

patients.

Therewerereportsofexplicitcommunicationbetweenthe

medical teamand thefamily onthe evolution ofthe case

anditsseriousness,proposedtreatmentand/orotherissues, including limitationsofinvasivetherapywhenindicatedin 96.5%(28/29)ofthe medicalrecords.Themedicalrecordof onepatient,whodiedwithdiseasecomplications,contained

noreportsofcommunicationbetweentheteamandhis

fam-ily.Therewerenoreportsofexplicitcommunicationbetween thestaffandpatientsinonlythreecases,whowereaged14, 15and17yearsatthetimeofdeath(#1,#7and#27).

Four records described the family’s desire to take the

patienthome.Allthepatientshadbeenundergoinglimited invasivetherapy.Fourpatientswerefollowedupbythehome careteam,buttheirmedicalrecordsreportednodesireofthe familytoreturnhome.Ofthesefourpatients,thefamiliesof twowerevisitedafterdeathbythehomecareteam.According totheirrecords,25ofthe29children(92.5%)were accompa-niedbyafamilymemberatthetimeofdeath,mostly(8/25 cases)onlybythemotheralthoughinfourcasesitwasonly thefather.Thefatherandmotherweretogetherinonlytwo cases.Intheothercases,thecompanionwasanotherfamily memberorcouldnotbeidentified.

(4)

complicationssecondary to treatment, were the only ones

whoreceivedcardiopulmonaryresuscitationpriortodeath.

Three patients, who had been tracheostomized, died on

mechanicalventilation,butnoneofthemreceived

cardiopul-monaryresuscitation.

Despite the limitation of invasive therapy having been

describedexplicitlyinthemedicalrecordsof26children,these

limits were only properly described in 16 (61.5%) patients;

thatis,in38.5%thetreatingphysiciandidnotclearlyexplain

whichtherapyshouldorshouldnotbedeliveredtothepatient,

butusedvaguetermssuchas“comfortmeasures”,“palliative

care”and“limitationoftherapeuticefforts”.

Discussion

Currently,around80%ofchildrenandadolescentsdiagnosed

withcancercanbecured.Inspiteofthehighratesofcure,

cancer-relatedmorbidityandmortalityisstillsignificant.3,4

Hence,dealingwiththisnewpatientprofileisachallenge.6

Impeccablecontrolofpainandothersymptomsisthemain

strategyinthepalliativeapproach.2Inpatientswithcancer,

painisanimportantfactorofdisease-relatedsuffering.5Asin

moststudies,painwasthemostprevalentsymptominthis

sample.7,10

Assessmentofpainshouldbedirectedduetothechild’sage

anddevelopment.2Wheneverpossible,thechild’sownreport

shouldbeesteemedandconsideredthegoldstandard.11Itis

recommendedtousescalestoassesstheintensity ofpain,

aswellastomonitortheprogressionoftreatment.1However,

theseinstrumentswerenotusedinthewardwherethestudy

wasconducted.

Lackofadequatecontrolofpainisatthecoreofthe

defi-cienciesobservedinpalliativecareindevelopingcountriesas

theavailabilityandconsumptionofopioids,consideredwide

indicatorsofcancer-relatedpainrelief,arestillrestricted.3,12

However,it wasobservedinthisstudy thatthemajorityof

patientswhoreportedpainwereprescribedopioids.

Non-pharmacologicalmeasureswerenotdescribedinthe

medical records. Such measures are part of the integral

management of pain and show synergistic effects todrug

treatment.13,14

Notonlyphysicalsymptomswereidentifiedinthisstudy.

Psychologicalsymptoms,suchasdepressionandsleep

dis-orders, were alsofound. Thesesymptoms are described in

the literature as an important cause of suffering for

chil-dren with cancer and they are often not addressed by

doctors.2,8,10

Asawayofrecognizingthecomplexityofcareneededby

patients withlife-threatening diseases, the involvementof

amultidisciplinaryteam isaprerequisitetodeliverquality

assistance.15 Itwasfound inthiscasestudy that a

signifi-cantnumberofpatientswereassistedbyamultidisciplinary

team, but the study design didnot allowanevaluation of

whetherthisfollow-upwaseffective.Itwasnotpossibleto

evaluatewhethertherewasinteractionwiththeteam,which

isessentialinmultidisciplinaryconditions,onlyby

examin-ingthemedicalrecords.Theoptimalfunctioningofthisteam

requirestraining,communicationandthesettingofrolesand

responsibilitiesofeachmember.15

The service provider where this study was conducted

hasno specialistsinpediatric palliativecare,but palliative

interventionsshouldnotbelimitedtospecialists.11 General

pediatriciansandpediatriciansfromdifferentfieldsshouldbe

abletohandlepalliativecareissues.6

Thetwopatientswho diedwithtreatment-related

com-plications were included inthis study since palliativecare

oughttobeinitiatedatthetimeofdiagnosis.6Moreover,only

fourofthepatientswhodiedwithdiseaseprogressionwere

receiving chemotherapywhen they died.In three ofthese

cases,chemotherapywasemployedasapalliativemeasure.

Researchers from differentcountrieshaveshownthat

chil-drenwhoreceiveend-of-lifechemotherapydisplayahigher

numberofsymptomsthanchildrenwhodonot,withgreater

likelihoodofinadequatecontrolofpain.8–10,16 Nevertheless,

the choice ofpalliativeor curative chemotherapyand

sus-pensionofchemotherapyisadifficultdecisionforboththe

medicalteamandthefamily.17Thisdifficultymaycause

med-icalstafftobereluctanttodiscloseanunfavorableprognosis

topatientsandtheirparents.16

Inmostofthecasesincludedinthisstudy,therewas

evi-denceofcommunicationbetweenteamsandfamilies.Three

records alsoreportedthatthere wasdirectcommunication

with thepatients, all ofwhomwere adolescents.However,

thesepatientsdidnottakepartinthedecisiontolimit

ther-apy, onlytheirparentsdid.Studiesemphasizethatdoctors

andparentsoughttotalktosickchildrenabouttheirfeelings

andanxieties.Avoidingthissortofcommunicationoverlooks

thefactthatmostofthetimetheyareawareoftheirsituation.6

Themedicalrecordsoffourfamiliesclearlyreportedthe

desiretotaketheirchildrenhome;allofthemwereawarethat

thediseasewasprogressing.Onlybyexaminingtherecords,

itisimpossibletoknowwhetherotherfamilieshadthesame

desire.Theplaceofdeathisanimportantindicatorof

end-of-lifequalityofcare.18Dyingathome,wheneverpossible,is

preferredbythemajorityoffamiliesofcancerpatients.19–21In

thisstudy,therewerereportsofafterdeathhomecarevisits

toonlytwochildren,whohadbeenfollowedupbythe

institu-tion’shomecareprogram.Afterdeathcareduringmourningis

alsoanimportantinterventioninpalliativecareandproduces

apositiveimpactonfamilies.

Decisionsonlimitationoffutiletherapyshouldbeshared

withpatientsandfamilies,22exactlyashappenedinthisstudy.

Intheonecaseinwhichtherewasadivergencebetweenthe

teamandthefamilyinspiteofprogressionofthedisease,the

patientcontinuedtoreceiveinvasiveinterventions,suchas

cardiopulmonaryresuscitation.

Tonellietal.evaluatedthecareprofiletopediatricpatients

whoprogressedtodeathinthesamehospitalasthecurrent

research.Participationofparentsindiscussionswasobserved

inonly20.8%ofthecases.23Thisfactdiffersfromtheresults

obtainedinthisstudy,whichfoundthatdiscussionswerehad

withtheparentsofallchildrenwithdiseaseprogression.Some

hypothesescanbesuggestedtoexplainthisdifference.Inthe

studybyTonellietal.,thedeathsofallpediatricpatientsat

thehospitalwereevaluated,includingpatientswithdifferent

diseasesandindifferentunits,suchasintheintensivecare

unitandoperatingrooms.23

Another factor that might have facilitated discussing

(5)

samplealreadyhadabondwiththemedicalteam,whichcan

beseenbytheintervalbetweenthediagnosisoftheunderlying

diseaseanddeath.24

Itshould also bestressed that in recent years medical

practicehasundergoneaculturalchange:the paternalistic

approachhasbeenreplacedbyanapproachthatrecognizes

theroleandimportanceofthefamilyandthepatient.25

Oneofthepossiblefactorsthataccountsforthisparadigm

shiftisthe currentBrazilianCode ofMedicalEthics,which

stressesthedutyofdoctorsto“providepalliativecareforpatients

withincurableandterminaldiseaseswithoutundertakinguseless therapeuticactionsandalwaystakingintoconsiderationthepatient’s manifestedwishor,shoulditproveimpossible,thewishofhis/her legalrepresentative”.26

Limitinginvasivetherapymeansexcludingfutile

interven-tions,whichdonothelptocontrolthe diseaseand donot

improvethepatient’squalityoflife.22Suchlimitationsshould

beindividualized.6,22Thesixtracheostomizedpatientsofthe

studycanberegardedasexamplesofthis.Allofthem

under-wentlimitation ofinvasive therapyandthreedied without

mechanicalventilatorysupport.Forthisreason,itis

impor-tantthatthephysicianrecordswhatshouldorshouldnotbe

done,afterhavinganappropriateconversationwiththe

fam-ily,ratherthanusingvaguetermssuchas“comfortmeasures”.

Itshouldbenotedthatsometermswereusedinappropriately.

Frequentlysomedoctors,whenevaluatingmedicalrecords,

consideredtheterm“palliativecaremeasures”tobesimilar

to“limitationoffutiletherapy”.

These findings reinforce the impression that there still

are heath workers who consider palliative careto be

end-of-life care.22 Some years ago,palliative and curative care

wereconsideredmutuallyexclusiveapproaches,and

pallia-tivecarewasonlyinitiatedafterallcurativepossibilitieshad

been exhausted. Currently, they are complementary forms

oftreatmentand palliativecareshouldbeimplemented at

thediagnoses oflife-threateningdiseases.Early integration

oftheseapproachesfacilitatesdiscussionofsensitiveissues

betweenmedicalstaffandfamilies,27,28inadditionto

improv-ingthequalityoflifeofpatients.29

Thelimitationsofthisstudyaremainlyrelatedtothe

rela-tivelysmallnumberofcasesandthelackofdataonthedeaths

thattookplaceathomeorinotherwards.However,

medi-calrecordswithclearandcomprehensibledescriptionswere

available.Thisisprobablyduetothefactthatthisisateaching

hospital.

Theresultsofthisstudyshowthatthehospitalwherethis

workwascarriedout,despitenothavingateamspecialized

inpediatricpalliativecare,meetsmostoftherequirements

forimplementingaspecificprogram.6Indevelopingcountries

suchasBrazil,therearestillcountlessdifficultiesto

follow-up children with cancer. Delays in diagnoses and limited

resources are someofthe obstacles found. Yet, suchfacts

should not hinder the development of pediatric palliative

care programs, which should be given priority in tertiary

hospitals.3,11

Theimportanceofmanagingpain andother symptoms

appropriatelyisevident.Forthisapproachtobetruly

effec-tive,involvementofworkersfromdifferentareas,withreal

integrationamongthem,isimperative.Othertoolscanalso

benefitthisapproach,suchastheuseofscales.

Despitetheinvolvementofseveralhealthworkerscaring

for thepatients included inthe study and the discussions

withmostofthemaboutlimitinginvasivetherapy,the

medi-calrecordsdidnotincludedescriptionsofawell-thought-out

treatmentplan.Thisplanconsistsofdiscussingwithpatients

andfamiliesinadvanceaboutwhatkindofassistancewillbe

delivered.Itshouldnotaddressonlymedicalaspects,butalso

socialissuessuchaswhatandwhoisimportanttothechild

andhisorherfamily.Thisplanningshouldbereassessedas

requiredbychangesintheclinicalstatus.6

Training communicationskills, developingthe abilityto

interactwithotherworkers,learningtocopewiththe

diffi-cultiesintrinsictotheprocessofdeathareamongtheitems

thatshouldbeimproved.27Inthisway,greatqualityassistance

willbedeliveredtopatientsthroughouttheprocessofdisease

regardlessofwhetherthefinaloutcomeiscureordeath.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1.WorldHealthOrganization.Cancerpainreliefandpalliative

careinchildren.Geneva:WHO;1998.Availablefrom:

http://whqlibdoc.who.int/publications/9241545127.pdf[cited 21.01.14].

2.HimelsteinBP.Palliativecareforinfants,children,

adolescents,andtheirfamilies.JPalliatMed.2006;9(1):163–81.

3.Rodriguez-GalindoC,FriedrichP,MorrisseyL,FrazierL.Global challengesinpediatriconcology.CurrOpinPediatr.

2013;25(1):3–15.

4.MinistériodaSaúde.InstitutoNacionaldeCâncer–INCA.

Câncerdacrianc¸aedoadolescentenoBrasil:dadosdo

registrodebasepopulacionalemortalidade;2008.Riode

Janeiro.Availablefrom:http://bvsms.saude.gov.br/bvs/

publicacoes/cancercriancaadolescentebrasil.pdf[cited 21.01.14].

5.PintoAC,CunhaAA,OtheroMB,BettebgaRT,BarbosaSM, ChibaT,etal.ManualdeCuidadosPaliativos/Academia NacionaldeCuidadosPaliativos.RiodeJaneiro:Diagraphic; 2009.

6.AmericanAcademyofPediatrics.CommitteeonBioethics andCommitteeonHospitalCare.Palliativecareforchildren. Pediatrics.2000;1062Pt1:351–7.

7.TheunissenJM,HoogerbruggePM,VanAchterbergT,PrinsJB, Vernooij-DassenMJ,VandenEndeCH.Symptomsinthe palliativephaseofchildrenwithcancer.PediatrBloodCancer. 2007;49(2):160–5.

8.CollinsJJ,ByrnesME,DunkelIJ,LapinJ,NadelT,ThalerHT, etal.Themeasurementofsymptomsinchildrenwithcancer. JPainSymptomManage.2000;19(5):363–77.

9.BerettaS,PolastriD,ClericiCA,CasanovaM,CefaloG,Ferrati A,etal.Endoflifeinchildrenwithcancer:experienceatthe PediatricOncologyDepartmentoftheIstitutoNazionale TumoriinMilan.PediatrBloodCancer.2010;54(1):88–91.

10.HeathJA,ClarkeNE,DonathSM,McCarthyM,AndersonVA, WolfeJ.Symptomsandsufferingattheendoflifeinchildren withcancer:anAustralianperspective.MedJAust.

2010;192(2):71–5.

(6)

12.DelgadoE,BarfielRC,BakerJN,HindsPS,YangJ,NambayanA, etal.Availabilityofpalliativecareservicesforchildrenwith cancerineconomicallydiverseregionsoftheworld.EurJ Cancer.2010;46(12):2260–6.

13.Vargas-SchafferG.IstheWHOanalgesicladderstillvalid? Twenty-fouryearsofexperience.CanFamPhys.

2010;56(6):514–7.

14.AraujoCM,OliveiraBM,PereiraYS.Avaliac¸ãoetratamentoda doremoncologiapediátrica.RevMédMinasGerais(Belo Horizonte).2012;22Suppl.7:S22–31.

15.VissersKCP,VanDenBranMWM,JacobsJ,GrootM,

VeldhovenC,VerhagenC,etal.Palliativemedicineupdate:a multidisciplinaryapproach.PainPract.2013;13(7):576–88.

16.TangST,HungYN,LiuTW,LinDT,ChenYC,WuSC,etal.

PediatricendoflifecareforTaiwanesechildrenwhodiedasa resultofcancerfrom2001through2006.JClinOncol. 2011;29(7):890–4.

17.TomlisonD,BartelsU,GammonJ,HindsPS,VolpeJ,BouffetE, etal.Chemotherapyversussupportivecarealoneinpediatric palliativecareforcancer:comparingthepreferencesof parentsandhealthcareprofessionals.CMAJ.

2011;183(17):E1252–8.

18.HouttekierD,CohenJ,SurkynJ,DeliensL.Studyofrecentand futuretrendsinplaceofdeathinBelgiumusingdeath certificatedata:ashiftfromhospitalstocarehomes.BMC PublicHealth.2011;11:228.

19.VickersJ,ThompsonA,CollinsGS,ChildsM,HainR.Place andprovisionofpalliativecareforchildrenwithprogressive cancer:astudybythepaediatriconcologynurses’

Forum/UnitedKingdomChildren’sCancerStudyGroup PalliativeCareWorkingGroup.JClinOncol.

2007;25(28):4472–6.

20.WidgerK,DaviesD,DrouinDJ,BeauneL,DaoustL,FarranRP, etal.PediatricpatientsreceivingpalliativecareinCanada: resultsofamulticenterreview.ArchPediatrAdolescMed. 2007;161(6):597–602.

21.KurashimaAY,LatorreMR,TeixeiraSA,CamargoB.Factors associatedwithlocationofdeathofchildrenwithcancerin palliativecare.PalliatSupportCare.2005;3(2):115–9.

22.PivaJP,GarciaPCR,LagoPM.Dilemasedificuldades envolvendodecisõesdefinaldevidaeofertadecuidados paliativosempediatria.RevBrasTerIntens.2011;23(1):78–86.

23.TonelliHA,MotaJA,OliveiraJS.Perfildascondutasmédicas queantecedemaoóbitodecrianc¸asemumhospitalterciário. JPediatr(RioJ).2005;81(2):118–25.

24.HellerKS,SolomonMZ.Continuityofcareandcaring:what matterstoparentsofchildrenwithlife-threatening conditions.JPediatrNurs.2005;20(5):335–46.

25.WeidnerNJ.PediatricpalliativeCare.CurrOncolRep. 2007;9(6):437–9.

26.ConselhoFederaldeMedicina.CódigodeÉticaMédica.

Availablefrom:www.portalmedico.org.br/novocodigo/

integra1.asp[cited21.01.14].

27.MoritzRD,DeicasA,CapalboM,ForteDN,KretzerLP,LagoP, etal.IIFórumdo“GrupodeEstudosdoFimdaVidadoCone Sul”:definic¸ões,recomendac¸õeseac¸õesintegradaspara cuidadospaliativosnaunidadedeterapiaintensivade adultosepediátrica.RevBrasTerIntens.2011;23(1):24–9.

28.MichelsonKN,SteinhornDM.PediatricEnd-of-Lifeissuesand palliativecare.ClinPediatrEmergMed.2007;8(3):212–9.

29.TemelJS,GreerJA,MusikanskyA,GallagherER,AdmaneS, JacksonVA,etal.Earlypalliativecareforpatientswith metastaticnon-small-celllungcancer.NEJM.

Imagem

Table 1 – Characteristics of the 29 hematological oncology patients who progressed to death.
Table 2 – Diagnosis, neurological sequelae and use of chemotherapy at the time of death.

Referências

Documentos relacionados

i) A condutividade da matriz vítrea diminui com o aumento do tempo de tratamento térmico (Fig.. 241 pequena quantidade de cristais existentes na amostra já provoca um efeito

Peça de mão de alta rotação pneumática com sistema Push Button (botão para remoção de broca), podendo apresentar passagem dupla de ar e acoplamento para engate rápido

Extinction with social support is blocked by the protein synthesis inhibitors anisomycin and rapamycin and by the inhibitor of gene expression 5,6-dichloro-1- β-

Neste trabalho o objetivo central foi a ampliação e adequação do procedimento e programa computacional baseado no programa comercial MSC.PATRAN, para a geração automática de modelos

Ousasse apontar algumas hipóteses para a solução desse problema público a partir do exposto dos autores usados como base para fundamentação teórica, da análise dos dados

Despercebido: não visto, não notado, não observado, ignorado.. Não me passou despercebido

Caso utilizado em neonato (recém-nascido), deverá ser utilizado para reconstituição do produto apenas água para injeção e o frasco do diluente não deve ser

Patentes que demonstraram a produção ou purificação do ácido succínico e/ou succinato como produto principal por.